Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

eVOLVE-02 study will evaluate the efficacy and safety of volrustomig as monotherapy or in combination with anti-cancer agents in participants with advanced/metastatic solid tumors.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Osoby w wieku 18 lat lub starsze.
  • Dostępność próbki guza do sprawdzenia poziomu białka PD-L1 (jeśli dotyczy).
  • Ogólny stan zdrowia pozwala na aktywność w stopniu 0 lub 1 (według skali ECOG).
  • Wykrywalna choroba na podstawie badań obrazowych (zgodnie z kryteriami RECIST 1.1).
  • Przewidywany czas życia co najmniej 12 tygodni.
  • Prawidłowe wyniki badań krwi (narządy i szpik kostny).
  • Waga ciała powyżej 35 kg.
  • Zdolność do udzielenia świadomej zgody na udział w badaniu.

✗ Disqualifies

  • Ucisk na rdzeń kręgowy.
  • Przerzuty do mózgu (chyba że są bezobjawowe, stabilne i nie wymagają leków sterydowych przez co najmniej 14 dni przed rozpoczęciem badania).
  • Niedawne leczenie przeciwnowotworowe, z którego skutków ubocznych pacjent nie wyzdrowiał całkowicie.
  • Przeciwwskazania do podania określonych leków (w zależności od części badania).
  • Inne aktywne choroby nowotworowe (z pewnymi wyjątkami).
  • Choroby, które mogłyby utrudnić udział w badaniu.
  • Aktywne infekcje (w tym gruźlica, niekontrolowane HIV, aktywne HBV/HCV).
  • Niedobory odporności.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 6, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (97)

Research Site

Los Angeles, United States

Research Site

Baltimore, United States

Research Site

New York, United States

Research Site

Stony Brook, United States

Research Site

Columbus, United States

Research Site

Philadelphia, United States

Research Site

Clayton, Australia

Research Site

Nedlands, Australia

Research Site

Ijuí, Brazil

Research Site

Londrina, Brazil

Research Site

Natal, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Santo André, Brazil

Research Site

São Caetano do Sul, Brazil

Research Site

Vitória, Brazil

Research Site

Vitória, Brazil

Research Site

Edmonton, Canada

Research Site

Montreal, Canada

Research Site

Anyang, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Bengbu, China

Research Site

Changchun, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Changsha, China

Research Site

Changsha, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Chengdu, China

Research Site

Chengdu, China

Research Site

Chongqing, China

Research Site

Chongqing, China

Research Site

Dongguan, China

Research Site

Dongguan, China

Research Site

Fuzhou, China

Research Site

Fuzhou, China

Research Site

Fuzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Harbin, China

Research Site

Hefei, China

Research Site

Jining, China

Research Site

Kunming, China

Research Site

Kunming, China

Research Site

Nanchang, China

Research Site

Nanjing, China

Research Site

Nanning, China

Research Site

Nanning, China

Research Site

Shandong, China

Research Site

Shandong, China

Research Site

Shandong, China

Research Site

Shandong, China

Research Site

Shanghai, China

Research Site

Shanghai, China

Research Site

Shenyang, China

Research Site

Tianjin, China

Research Site

Tianjin, China

Research Site

Wuhan, China

Research Site

Wuhan, China

Research Site

Wuhan, China

Research Site

Wuhan, China

Research Site

Wuhou District, China

Research Site

Zhengzhou, China

Research Site

Cologne, Germany

Research Site

Frankfurt, Germany

Research Site

Gauting, Germany

Research Site

Großhansdorf, Germany

Research Site

Hamburg, Germany

Research Site

Heidelberg, Germany

Research Site

Mainz, Germany

Research Site

Münster, Germany

Research Site

Offenbach, Germany

Research Site

Regensburg, Germany

Research Site

Alessandria, Italy

Research Site

Bergamo, Italy

Research Site

Orbassano, Italy

Research Site

Kashiwa, Japan

Research Site

Yokohama, Japan

Research Site

Incheon, South Korea

Research Site

Namdong-gu, South Korea

Research Site

Seoul, South Korea

Research Site

Seoul, South Korea

Research Site

Kaohsiung City, Taiwan

Research Site

Kaohsiung City, Taiwan

Research Site

Taichung, Taiwan

Research Site

Taipei, Taiwan

Research Site

Taipei, Taiwan

Research Site

Cambridge, United Kingdom

Research Site

Glasgow, United Kingdom

Research Site

Manchester, United Kingdom

Research Site

Hanoi, Vietnam

Research Site

Ho Chi Minh City, Vietnam

Trial contact

AstraZeneca Clinical Study Information Center

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.